• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION IX; MAIN BODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION IX; MAIN BODY Back to Search Results
Model Number TV-AB2980-I
Device Problem Insufficient Information (3190)
Patient Problems Calcium Deposits/Calcification (1758); Failure of Implant (1924)
Event Date 02/09/2021
Event Type  Injury  
Manufacturer Narrative
The device involved in this event will not be returned for evaluation as it remains implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by the clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event Description
The patient was initially implanted with the ovation ix abdominal stent graft system to treat an abdominal aortic aneurysm (aaa).An intraoperative type 1a endoleak was identified.The physician elected to implant a non- endologix bare metal stent (palmaz) and perform ballooning however a small intraoperative type 1a endoleak was still present.The procedure was complete and the patient will be monitored.The patient will be re-evaluated at the 30 day follow up.
 
Event Description
The patient was initially implanted with the ovation ix abdominal stent graft system to treat an abdominal aortic aneurysm (aaa).An intraoperative type 1a endoleak was identified.The physician elected to implant a non-endologix bare metal stent (palmaz) and perform ballooning however a small intraoperative type 1a endoleak was still present.The procedure was complete and the patient will be monitored.The patient will be re-evaluated at the 30 day follow up.Additional information received indicating that the ct (computed tomography) scan completed 48 hours post initial implant shows there is little to no sign of a remaining type ia endoleak.The patient is reportedly doing well.
 
Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix does not confirm the reported type 1a endoleak.The clinical evaluation also shows reasonable evidence to suggest thickened calcifications in the aortic neck (cautionary product use), but it is unknown if this contributed to the reported event.This finding was discovered during an examination of the procedure planning dated (b)(6) 2020.Procedure-related harms, device, user, procedure, or anatomy relatedness of this event could not be determined with the medical records available for review.The final patient status was reported to be doing well under surveillance.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.Correction: b5, g3, g4, h6; h6 evaluation result codes - remove 3233 h6 evaluation conclusion codes - remove 11.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Type of Device
MAIN BODY
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
MDR Report Key11425740
MDR Text Key247669137
Report Number3008011247-2021-00018
Device Sequence Number1
Product Code MIH
UDI-Device IdentifierM701TVAB2980I1
UDI-Public+M701TVAB2980I1/$$3220829FS08281908Q
Combination Product (y/n)N
PMA/PMN Number
P120006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Remedial Action Other
Type of Report Initial,Followup
Report Date 02/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date08/29/2022
Device Model NumberTV-AB2980-I
Device Lot NumberFS082819-08
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/09/2021
Initial Date FDA Received03/05/2021
Supplement Dates Manufacturer Received03/25/2021
Supplement Dates FDA Received04/20/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
OVATION IX ILIAC LIMB, SN (B)(6).; OVATION IX ILIAC LIMB, SN (B)(6).
Patient Outcome(s) Required Intervention;
Patient Age80 YR
-
-